Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21
Phase 31

Trial Status

Completed1
Recruiting1
Terminated1

Role Distribution

Principal Investigator1
Other Roles2
PI Rate33%

Activity Timeline

Clinical Trials (3)

NCT07572162Recruiting
Post-market Safety Study of LUMISIGHT
Hypersensitivity Reactions
PrincipalinvestigatorStart date: 2026-09-30
NCT04440982Phase 2Terminated
Feasibility Study of Intraoperative Detection of Residual Cancer in Breast Cancer Patients
Breast CancerNeoadjuvant Therapy
StudydirectorStart date: 2020-09-01
NCT03686215Phase 3Completed
Investigation of Novel Surgical Imaging for Tumor Excision
Breast Cancer
StudydirectorStart date: 2019-11-04

Research Network

Collaboration Network

2 collaborators·1 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Lumicell, Inc.

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Barbara Smith, MD, PhD

Massachusetts General Hospital

Related
2 trials

Shared therapeutic areas:

Breast CancerNeoadjuvant Therapy

Worked with same sponsors:

Lumicell, Inc.National Cancer Institute (NCI)
Collaborated on 2 trials
Similarity Score28%

Lizhi Niu, PhD

Fuda Cancer Hospital

Related
31 trials

Shared therapeutic areas:

Breast Cancer
Similarity Score10%

Herui Yao, PhD

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Related
11 trials

Shared therapeutic areas:

Breast Cancer
Similarity Score10%

Dong-Xin Wang, MD, PhD

Peking University First Hospital

Related
74 trials

Shared therapeutic areas:

Breast Cancer
Similarity Score10%

Ali MA Ismail, lecturer

Cairo University

Related
27 trials

Shared therapeutic areas:

Breast Cancer
Similarity Score10%

Steven A Rosenberg, M.D.

National Cancer Institute (NCI)

Related
32 trials

Shared therapeutic areas:

Breast Cancer

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score10%

Zhaohui Zhu, MD

Peking Union Medical College Hospital

Related
19 trials

Shared therapeutic areas:

Neoadjuvant Therapy
Similarity Score10%

John D. Hainsworth, MD

SCRI Development Innovations, LLC

Related
26 trials

Shared therapeutic areas:

Breast Cancer
Similarity Score10%

Aminah Jatoi, MD

Mayo Clinic

Related
29 trials

Shared therapeutic areas:

Breast Cancer

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score10%

Jamie Ostroff, PhD

Memorial Sloan Kettering Cancer Center

Related
17 trials

Shared therapeutic areas:

Breast Cancer

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score10%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT07572162PrincipalInvestigator

Post-market Safety Study of LUMISIGHT

Hypersensitivity Reactions
Recruiting
NCT04440982Phase 2StudyDirector

Feasibility Study of Intraoperative Detection of Residual Cancer in Breast Cancer Patients

Breast CancerNeoadjuvant Therapy
Terminated
NCT03686215Phase 3StudyDirector

Investigation of Novel Surgical Imaging for Tumor Excision

Breast Cancer
Completed

All 3 trials loaded